1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-933.36%
Negative EBIT growth while ACB.TO is at 22.47%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-933.36%
Negative operating income growth while ACB.TO is at 25.56%. Joel Greenblatt would press for urgent turnaround measures.
-1137.19%
Negative net income growth while ACB.TO stands at 26.78%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-1163.64%
Negative EPS growth while ACB.TO is at 26.60%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1163.64%
Negative diluted EPS growth while ACB.TO is at 26.60%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-66.98%
Negative OCF growth while ACB.TO is at 27.52%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-66.98%
Negative FCF growth while ACB.TO is at 27.52%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
85.06%
10Y OCF/share CAGR above 1.5x ACB.TO's 22.18%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
85.06%
Positive OCF/share growth while ACB.TO is negative. John Neff might see a comparative advantage in operational cash viability.
85.06%
3Y OCF/share CAGR above 1.5x ACB.TO's 14.37%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
46.58%
Net income/share CAGR at 50-75% of ACB.TO's 86.30%. Martin Whitman might question if the firm’s product or cost base lags behind.
46.58%
Positive 5Y CAGR while ACB.TO is negative. John Neff might view this as a strong mid-term relative advantage.
46.58%
3Y net income/share CAGR 1.25-1.5x ACB.TO's 34.32%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-56.80%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-56.80%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-56.80%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.52%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-9.38%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-22.07%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
933.35%
We expand SG&A while ACB.TO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.